News and Trends 31 Jan 2017 New British Biotech-Academia Alliance takes on Cardiovascular Disease …key to treating many diseases, ranging from Alzheimer’s to cancer. However, their conformational flexibility in solution is a huge challenge that leads most candidates to fail. Heptares’ StaR technology addresses… January 31, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 6 Feb 2020 Valbiotis Teams up with Nestlé to Reduce Type 2 Diabetes Risk …Valbiotis’ lead candidate is a food supplement and not a medical treatment, the partners don’t legally need to complete clinical trials to take it to market. Therefore, they may decide… February 6, 2020 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 22 Feb 2024 TIL therapies: the impact on cancer research …with is Obsidian Therapeutics, which is on a mission to limit toxicities when treating patients with melanoma. Its lead candidate OBX-115 is a TIL cell therapy that is genetically modified… February 22, 2024 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 28 Apr 2020 AskBio Takes Over French Gene Therapy Company to Treat Alzheimer’s and Huntington’s …manufacturing capacity will help to accelerate BrainVectis’ lead candidate for Huntington’s into phase I testing. In return, AskBio gets to expand its list of target indications. “AskBio recognized the scientific… April 28, 2020 - 3 minutesmins - By David Kirk Share WhatsApp Twitter Linkedin Email
In Depth 5 Apr 2023 Antimicrobial peptides: a promising class to tackle antimicrobial resistance …down rapidly when they encounter bodily fluids, such as blood. They can also be costly to produce. However, efforts to create product candidates from antimicrobial peptides are expected to accelerate… April 5, 2023 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 30 May 2023 Pancreatic cancer microbiome discovery holds treatment hope …secure diverse IR candidates, the project involves comprehensive genomic and functional analysis of disease-associated microbiomes and bacteriophages. Additionally, the project aims to elucidate the mode of action (MoA) of IR-related… May 30, 2023 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 10 Jun 2019 The 10 Biotech Companies in London to Keep an Eye on in 2019 …in the city, these are the 10 biotech companies in London you need to know. Founded in 2015, Orchard Therapeutics is developing multiple gene therapy candidates to treat rare genetic… June 10, 2019 - 5 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Opinion 12 Dec 2022 Artificial intelligence: a new era in rare genetic disease diagnosis …candidate variants in undiagnosed genetic disorders and better inform healthcare professionals. By quickly identifying the most promising candidate variants for interpretation, AI-driven tools are revolutionary, supporting experts in making fast,… December 12, 2022 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
In Depth 14 May 2025 The stem cell race for Parkinson’s disease: Recent studies show significant promise …from the U.S. Food and Drug Administration (FDA) to progress the candidate in January 2025. This came after the candidate, which is made up of immature brain cells called dopaminergic… May 14, 2025 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 15 Aug 2023 Can stem cell treatment repair damaged knees? …the hyperbaric oxygen chamber is to encourage stem cells to produce capillaries and blood vessels. Is stem cell therapy a worthy candidate to target knee arthritis? Meanwhile, knee arthritis (osteoarthritis)… August 15, 2023 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 28 Jan 2025 ITM-11 succeeds in phase 3: The first big win for radiopharma? …more and more investment and candidates are showing great promise, the field still awaits its first big win. The COMPETE trial is the first to show that a targeted radiopharmaceutical… January 28, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 17 Oct 2017 Genfit Gets €180M Cash Injection to Bring its Pipeline to Market Elafibranor, Genfit’s lead candidate, will continue its march towards the market with the added boost of massive financial support. Genfit is a leader in the development of diagnostic tools and… October 17, 2017 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email